{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:19:56Z","timestamp":1789712396728,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Horus Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12325-025-03139-1","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:08:46Z","timestamp":1741853326000},"page":"2219-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of Oxidative Stress and Inflammation in Patients with Symptomatic Dry Eye Disease Treated with a Preservative-Free Ophthalmic Emulsion Combining Alpha-Lipoic Acid and High Molecular Weight Sodium Hyaluronate"],"prefix":"10.1007","volume":"42","author":[{"given":"Laure","family":"Chauchat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Sahyoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Calonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"3139_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276\u201383. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008.","journal-title":"Ocul Surf"},{"key":"3139_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067007","volume":"13","author":"KG Boboridis","year":"2023","unstructured":"Boboridis KG, Messmer EM, Ben\u00edtez-Del-Castillo J, et al. Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey. BMJ Open. 2023;13:e067007. https:\/\/doi.org\/10.1136\/bmjopen-2022-067007.","journal-title":"BMJ Open"},{"key":"3139_CR3","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1167\/iovs.10-5390","volume":"51","author":"BD Sullivan","year":"2010","unstructured":"Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51:6125\u201330. https:\/\/doi.org\/10.1167\/iovs.10-5390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3139_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/ICL.0000000000000103","volume":"41","author":"J Gonz\u00e1lez-Cavada","year":"2015","unstructured":"Gonz\u00e1lez-Cavada J, Martin R, Pi\u00f1ero DP. Clinical characterization of asymptomatic or minimally symptomatic young patients showing signs compatible with dry eye: a pilot study. Eye Contact Lens. 2015;41:171\u20136. https:\/\/doi.org\/10.1097\/ICL.0000000000000103.","journal-title":"Eye Contact Lens"},{"key":"3139_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","volume":"11","author":"C Baudouin","year":"2013","unstructured":"Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11:246\u201358. https:\/\/doi.org\/10.1016\/j.jtos.2013.07.003.","journal-title":"Ocul Surf"},{"key":"3139_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100:300\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307415.","journal-title":"Br J Ophthalmol"},{"key":"3139_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.preteyeres.2018.11.007","volume":"71","author":"C Baudouin","year":"2019","unstructured":"Baudouin C, Rolando M, Benitez Del Castillo JM, et al. Reconsidering the central role of mucins in dry eye and ocular surface diseases. Prog Retin Eye Res. 2019;71:68\u201387. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.11.007.","journal-title":"Prog Retin Eye Res"},{"key":"3139_CR8","doi-asserted-by":"publisher","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","volume":"59","author":"T Yamaguchi","year":"2018","unstructured":"Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. 2018;59:DES192\u20139. https:\/\/doi.org\/10.1167\/iovs.17-23651.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3139_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/aos.14892","volume":"100","author":"V Navel","year":"2022","unstructured":"Navel V, Sapin V, Henrioux F, et al. Oxidative and antioxidative stress markers in dry eye disease: a systematic review and meta-analysis. Acta Ophthalmol. 2022;100:45\u201357. https:\/\/doi.org\/10.1111\/aos.14892.","journal-title":"Acta Ophthalmol"},{"key":"3139_CR10","doi-asserted-by":"publisher","first-page":"DES163","DOI":"10.1167\/iovs.17-23402","volume":"59","author":"M Dogru","year":"2018","unstructured":"Dogru M, Kojima T, Simsek C, Tsubota K. Potential role of oxidative stress in ocular surface inflammation and dry eye disease. Invest Ophthalmol Vis Sci. 2018;59:DES163\u20138. https:\/\/doi.org\/10.1167\/iovs.17-23402.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3139_CR11","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1111\/aos.13526","volume":"96","author":"S Seen","year":"2018","unstructured":"Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018;96:e412\u201320. https:\/\/doi.org\/10.1111\/aos.13526.","journal-title":"Acta Ophthalmol"},{"key":"3139_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/JEP.S237487","volume":"13","author":"M Baiula","year":"2021","unstructured":"Baiula M, Spampinato S. Experimental pharmacotherapy for dry eye disease: a review. J Exp Pharmacol. 2021;13:345\u201358. https:\/\/doi.org\/10.2147\/JEP.S237487.","journal-title":"J Exp Pharmacol"},{"key":"3139_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.biopha.2018.05.145","volume":"105","author":"AM Fayez","year":"2018","unstructured":"Fayez AM, Zakaria S, Moustafa D. Alpha lipoic acid exerts antioxidant effect via Nrf2\/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats. Biomed Pharmacother. 2018;105:428\u201333. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.145.","journal-title":"Biomed Pharmacother"},{"key":"3139_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","volume":"128","author":"KL Miller","year":"2010","unstructured":"Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128:94\u2013101. https:\/\/doi.org\/10.1001\/archophthalmol.2009.356.","journal-title":"Arch Ophthalmol"},{"key":"3139_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","volume":"33","author":"JR Grubbs","year":"2014","unstructured":"Grubbs JR, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea. 2014;33:215\u20138. https:\/\/doi.org\/10.1097\/ICO.0000000000000038.","journal-title":"Cornea"},{"key":"3139_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1046\/j.1475-1313.2002.00049.x","volume":"22","author":"N Efron","year":"2002","unstructured":"Efron N, Morgan PB, Jagpal R. Validation of computer morphs for grading contact lens complications. Ophthalmic Physiol Opt. 2002;22:341\u20139. https:\/\/doi.org\/10.1046\/j.1475-1313.2002.00049.x.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3139_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640\u201350. https:\/\/doi.org\/10.1097\/00003226-200310000-00008.","journal-title":"Cornea"},{"key":"3139_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.clae.2019.03.005","volume":"42","author":"E Yasar","year":"2019","unstructured":"Yasar E, Kemeriz F, Gurlevik U. Evaluation of dry eye disase and meibomian gland dysfunction with meibography in seborrheic dermatitis. Cont Lens Anterior Eye. 2019;42:675\u20138. https:\/\/doi.org\/10.1016\/j.clae.2019.03.005.","journal-title":"Cont Lens Anterior Eye"},{"key":"3139_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s1542-0124(12)70185-4","volume":"7","author":"Y Chen","year":"2009","unstructured":"Chen Y, Mehta G, Vasiliou V. Antioxidant defenses in the ocular surface. Ocul Surf. 2009;7:176\u201385. https:\/\/doi.org\/10.1016\/s1542-0124(12)70185-4.","journal-title":"Ocul Surf"},{"key":"3139_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3129\/i10-062","volume":"46","author":"RM Corrales","year":"2011","unstructured":"Corrales RM, Galarreta D, Herreras J, et al. Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects. Can J Ophthalmol. 2011;46:35\u20139. https:\/\/doi.org\/10.3129\/i10-062.","journal-title":"Can J Ophthalmol"},{"key":"3139_CR21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.01.019","volume":"180","author":"T Kojima","year":"2012","unstructured":"Kojima T, Wakamatsu TH, Dogru M, et al. Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice. Am J Pathol. 2012;180:1879\u201396. https:\/\/doi.org\/10.1016\/j.ajpath.2012.01.019.","journal-title":"Am J Pathol"},{"key":"3139_CR22","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.14670\/HH-23.1477","volume":"23","author":"J Cejkov\u00e1","year":"2008","unstructured":"Cejkov\u00e1 J, Ardan T, Simonov\u00e1 Z, et al. Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sj\u00f6gren\u2019s syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol. 2008;23:1477\u201383. https:\/\/doi.org\/10.14670\/HH-23.1477.","journal-title":"Histol Histopathol"},{"key":"3139_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00417-022-05784-6","volume":"261","author":"Z Li","year":"2023","unstructured":"Li Z, Han Y, Ji Y, et al. The effect of a-Lipoic acid (ALA) on oxidative stress, inflammation, and apoptosis in high glucose\u2013induced human corneal epithelial cells. Graefes Arch Clin Exp Ophthalmol. 2023;261:735\u201348. https:\/\/doi.org\/10.1007\/s00417-022-05784-6.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3139_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/mnfr.201200608","volume":"57","author":"L Rochette","year":"2013","unstructured":"Rochette L, Ghibu S, Richard C, et al. Direct and indirect antioxidant properties of \u03b1-lipoic acid and therapeutic potential. Mol Nutr Food Res. 2013;57:114\u201325. https:\/\/doi.org\/10.1002\/mnfr.201200608.","journal-title":"Mol Nutr Food Res"},{"key":"3139_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.31083\/j.fbl2707202","volume":"27","author":"AM Roszkowska","year":"2022","unstructured":"Roszkowska AM, Spinella R, Oliverio GW, et al. Effects of the topical use of the natural antioxidant alpha-lipoic acid on the ocular surface of diabetic patients with dry eye symptoms. Front Biosci (Landmark Ed). 2022;27:202. https:\/\/doi.org\/10.31083\/j.fbl2707202.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3139_CR26","doi-asserted-by":"publisher","first-page":"5194239","DOI":"10.1155\/2016\/5194239","volume":"2016","author":"OA Kost","year":"2016","unstructured":"Kost OA, Beznos OV, Davydova NG, et al. Superoxide dismutase 1 nanozyme for treatment of eye inflammation. Oxid Med Cell Longev. 2016;2016:5194239. https:\/\/doi.org\/10.1155\/2016\/5194239.","journal-title":"Oxid Med Cell Longev"},{"key":"3139_CR27","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/1440-1681.13373","volume":"47","author":"TA Ajith","year":"2020","unstructured":"Ajith TA. Alpha-lipoic acid: a possible pharmacological agent for treating dry eye disease and retinopathy in diabetes. Clin Exp Pharmacol Physiol. 2020;47:1883\u201390. https:\/\/doi.org\/10.1111\/1440-1681.13373.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3139_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40824-021-00228-4","volume":"25","author":"BM Lee","year":"2021","unstructured":"Lee BM, Park SJ, Noh I, Kim C-H. The effects of the molecular weights of hyaluronic acid on the immune responses. Biomater Res. 2021;25:27. https:\/\/doi.org\/10.1186\/s40824-021-00228-4.","journal-title":"Biomater Res"},{"key":"3139_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1947603517749919","volume":"10","author":"R Altman","year":"2019","unstructured":"Altman R, Bedi A, Manjoo A, et al. Anti-inflammatory effects of intra-articular hyaluronic acid: a systematic review. Cartilage. 2019;10:43\u201352. https:\/\/doi.org\/10.1177\/1947603517749919.","journal-title":"Cartilage"},{"key":"3139_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/563818","volume":"2015","author":"JM Cyphert","year":"2015","unstructured":"Cyphert JM, Trempus CS, Garantziotis S. Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int J Cell Biol. 2015;2015:563818. https:\/\/doi.org\/10.1155\/2015\/563818.","journal-title":"Int J Cell Biol"},{"key":"3139_CR31","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1111\/aos.16609","volume":"102","author":"N Medic","year":"2024","unstructured":"Medic N, Boldin I, Berisha B, et al. Application frequency - key indicator for the efficiency of severe dry eye disease treatment - evidence for the importance of molecular weight of hyaluronan in lubricating agents. Acta Ophthalmol. 2024;102:e663\u201371. https:\/\/doi.org\/10.1111\/aos.16609.","journal-title":"Acta Ophthalmol"},{"key":"3139_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539\u201374. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001.","journal-title":"Ocul Surf"},{"key":"3139_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jtos.2021.05.003","volume":"21","author":"RB Singh","year":"2021","unstructured":"Singh RB, Liu L, Anchouche S, et al. Ocular redness: I\u2014etiology, pathogenesis, and assessment of conjunctival hyperemia. Ocul Surf. 2021;21:134\u201344. https:\/\/doi.org\/10.1016\/j.jtos.2021.05.003.","journal-title":"Ocul Surf"},{"key":"3139_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130:90\u2013100. https:\/\/doi.org\/10.1001\/archophthalmol.2011.364.","journal-title":"Arch Ophthalmol"},{"key":"3139_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/1120672118795399","volume":"29","author":"J Benitez-Del-Castillo","year":"2019","unstructured":"Benitez-Del-Castillo J, Cantu-Dibildox J, Sanz-Gonz\u00e1lez SM, et al. Cytokine expression in tears of patients with glaucoma or dry eye disease: a prospective, observational cohort study. Eur J Ophthalmol. 2019;29:437\u201343. https:\/\/doi.org\/10.1177\/1120672118795399.","journal-title":"Eur J Ophthalmol"},{"key":"3139_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258203","volume":"16","author":"YH Lee","year":"2021","unstructured":"Lee YH, Bang S-P, Shim K-Y, et al. Association of tear matrix metalloproteinase 9 immunoassay with signs and symptoms of dry eye disease: a cross-sectional study using qualitative, semiquantitative, and quantitative strategies. PLoS ONE. 2021;16:e0258203. https:\/\/doi.org\/10.1371\/journal.pone.0258203.","journal-title":"PLoS ONE"},{"key":"3139_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/636812","volume":"2013","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz L, Ghosh-Mitra A, Shatos MA, et al. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediat Inflamm. 2013;2013:636812. https:\/\/doi.org\/10.1155\/2013\/636812.","journal-title":"Mediat Inflamm"},{"key":"3139_CR38","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1167\/iovs.13-13128","volume":"54","author":"T Ohguchi","year":"2013","unstructured":"Ohguchi T, Kojima T, Ibrahim OM, et al. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (Sod1) knockout mice. Invest Ophthalmol Vis Sci. 2013;54:7793\u2013802. https:\/\/doi.org\/10.1167\/iovs.13-13128.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3139_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2023.105908","volume":"143","author":"C Guarise","year":"2023","unstructured":"Guarise C, Acquasaliente L, Pasut G, et al. The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model. J Mech Behav Biomed Mater. 2023;143:105908. https:\/\/doi.org\/10.1016\/j.jmbbm.2023.105908.","journal-title":"J Mech Behav Biomed Mater"},{"key":"3139_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0378-5173(89)90193-2","volume":"51","author":"MF Saettone","year":"1989","unstructured":"Saettone MF, Chetoni P, Tilde Torracca M, et al. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int J Pharm. 1989;51:203\u201312. https:\/\/doi.org\/10.1016\/0378-5173(89)90193-2.","journal-title":"Int J Pharm"},{"key":"3139_CR41","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3390\/ijms21103516","volume":"21","author":"T Kojima","year":"2020","unstructured":"Kojima T, Nagata T, Kudo H, et al. The effects of high molecular weight hyaluronic acid eye drop application in environmental dry eye stress model mice. Int J Mol Sci. 2020;21:3516. https:\/\/doi.org\/10.3390\/ijms21103516.","journal-title":"Int J Mol Sci"},{"key":"3139_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099328","volume":"9","author":"OMA Ibrahim","year":"2014","unstructured":"Ibrahim OMA, Dogru M, Matsumoto Y, et al. Oxidative stress induced age dependent meibomian gland dysfunction in Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice. PLoS ONE. 2014;9:e99328. https:\/\/doi.org\/10.1371\/journal.pone.0099328.","journal-title":"PLoS ONE"},{"key":"3139_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","volume":"65","author":"S Sabeti","year":"2020","unstructured":"Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Surv Ophthalmol. 2020;65:205\u201317. https:\/\/doi.org\/10.1016\/j.survophthal.2019.08.007.","journal-title":"Surv Ophthalmol"},{"key":"3139_CR44","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/aos.15159","volume":"100","author":"L Hynnekleiv","year":"2022","unstructured":"Hynnekleiv L, Magno M, Vernhardsdottir RR, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 2022;100:844\u201360. https:\/\/doi.org\/10.1111\/aos.15159.","journal-title":"Acta Ophthalmol"},{"key":"3139_CR45","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/polym12081800","volume":"12","author":"P Snetkov","year":"2020","unstructured":"Snetkov P, Zakharova K, Morozkina S, et al. Hyaluronic acid: the influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer. Polymers (Basel). 2020;12:1800. https:\/\/doi.org\/10.3390\/polym12081800.","journal-title":"Polymers (Basel)"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03139-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:51:11Z","timestamp":1744872671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03139-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03139-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Camille Guerin, Laure Chauchat and Marwan Sahyoun were working for Horus Pharma at the time of publication. Michel Guillon was contracted by Horus Pharma to serve as the Clinical Research Organisation for this clinical trial. Margarita Calonge had nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Integrated Research Application System (IRAS; Centralized National Research Ethics Service) of the East of England\u2014Cambridge Central Research Ethics Committee under the reference number 19\/EE\/0315. The study was conducted in accordance with the current ethical principles of the Declaration of Helsinki and in accordance with the current legislation on clinical research in UK. All patients were given and understood the Participant Information Sheet in English; and read, signed, and dated an informed consent form before starting the study. The study was registered in the ISRCTN database under number 17861788.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}